administered dose for drugs dosed per kg body weight [Design Issues]

posted by luvblooms  – India, 2014-08-12 08:28 (4339 d 17:05 ago) – Posting: # 13364
Views: 9,438

Hi Helmut


❝ I think that EMA’s draft guidance can easily be misinterpreted (see my remarks at the end of this post). Maybe the guidance’s wording is just ambiguous. The 500 mg strength is OK, but should not be interpreted as the suitable dose – which should still be calculated according to the common poso­logy.


Totally agreed to the point raised by you. Also the study has to be done in patients thus using just 500 mg (where as the dose based on BSA lies in 1500-2500 mg) is also not ethically right. We have already asked for clarification on the same from EMEA. Lets see if we can get a reply.

IF the study has to be done on healthy volunteers (after regulatory consultation) using 500 mg should be ok.
Remember Imatinib guidance

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
239 visitors (0 registered, 239 guests [including 23 identified bots]).
Forum time: 01:34 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5